New radiation drug trial offers hope for tough brain tumors
Disease control
Recruiting now
This study is testing whether a targeted radiation drug called [177Lu]Lu-DOTATATE can better control progressing brain meningioma tumors compared to standard treatments. About 153 adults whose tumors are growing will be randomly assigned to receive either the new drug or their do…
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC